Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
45.06
+0.23 (0.51%)
At close: Mar 9, 2026, 4:00 PM EDT
44.24
-0.82 (-1.82%)
After-hours: Mar 9, 2026, 5:18 PM EDT
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $2.17 billion as of March 9, 2026. Its market cap has increased by 306.98% in one year.
Market Cap
2.17B
Enterprise Value
1.77B
1-Year Change
306.98%
Ranking
Category
Stock Price
$45.06
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $2.17B, an increase of 216.43%. That is a compound annual growth rate of 186.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.16B | 8.21% |
| Dec 31, 2025 | 1.99B | 190.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 2.29B |
| Ocular Therapeutix | 2.24B |
| Day One Biopharmaceuticals | 2.19B |
| Zai Lab | 2.19B |
| Galapagos NV | 2.15B |
| Ascentage Pharma Group International | 2.13B |
| Iovance Biotherapeutics | 2.11B |
| Mineralys Therapeutics | 2.10B |